
Sign up to save your podcasts
Or


Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.
By The Lancet NeurologyDiscussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.

43,687 Listeners

299 Listeners

503 Listeners

53 Listeners

113,121 Listeners

94 Listeners

518 Listeners

189 Listeners

59 Listeners

80 Listeners

0 Listeners